Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $365.6500 (1.69%) ($359.5000 - $368.2400) on Fri. Nov. 30, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 53 | Latest Price | $365.6500(1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.4% a day on average for past five trading days. | Weekly Trend | REGN advances 2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(60%) XLV(49%) IVW(42%) IWF(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -1.03% in a week (0% probabilities). VXX(-11%) UUP(-11%) TLT(-7%) DIA(-5%) IFRA(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $359.13(1.82%) | 10 Day Moving Average | $350.68(4.27%) | 20 Day Moving Average | $350.91(4.2%) | To recent high | -10.5% | To recent low | 8.9% | Market Cap | $38.769b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |